196 related articles for article (PubMed ID: 20228826)
1. Paradoxical relationship between RAVE (relative activity versus endocytosis) values of several opioid receptor agonists and their liability to cause dependence.
Wang YH; Sun JF; Tao YM; Xu XJ; Chi ZQ; Liu JG
Acta Pharmacol Sin; 2010 Apr; 31(4):393-8. PubMed ID: 20228826
[TBL] [Abstract][Full Text] [Related]
2. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
Xu H; Partilla JS; Wang X; Rutherford JM; Tidgewell K; Prisinzano TE; Bohn LM; Rothman RB
Synapse; 2007 Mar; 61(3):166-75. PubMed ID: 17152090
[TBL] [Abstract][Full Text] [Related]
3. Effects of ohmefentanyl stereoisomers on phosphorylation of cAMP- response element binding protein in cultured rat hippocampal neurons.
Gao C; Chen LW; Tao YM; Chen J; Xu XJ; Chi ZQ
Acta Pharmacol Sin; 2003 Dec; 24(12):1253-8. PubMed ID: 14653953
[TBL] [Abstract][Full Text] [Related]
4. Binding affinity to and dependence on some opioids in Sf9 insect cells expressing human mu-opioid receptor.
Liu ZH; He Y; Jin WQ; Chen XJ; Zhang HP; Shen QX; Chi ZQ
Acta Pharmacol Sin; 2003 Sep; 24(9):859-63. PubMed ID: 12956932
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic treatment of ohmefentanyl stereoisomers on cyclic AMP formation in Sf9 insect cells expressing human mu-opioid receptors.
Liu ZH; He Y; Jin WQ; Chen XJ; Shen QX; Chi ZQ
Life Sci; 2004 Apr; 74(24):3001-8. PubMed ID: 15051423
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats.
Hashimoto T; Saito Y; Yamada K; Hara N; Kirihara Y; Tsuchiya M
Anesthesiology; 2006 Sep; 105(3):574-80. PubMed ID: 16931992
[TBL] [Abstract][Full Text] [Related]
7. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
8. Effects of opioid receptor agonists on cAMP second messenger system.
Liu JG; Gong ZH; Qin BY
Zhongguo Yao Li Xue Bao; 1999 May; 20(5):452-6. PubMed ID: 10678096
[TBL] [Abstract][Full Text] [Related]
9. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
10. Intracellular cAMP assay and Eu-GTP-γS binding studies of chimeric opioid peptide YFa.
Kumar K; Kumar S; Kurupati RK; Seth MK; Mohan A; Hussain ME; Pasha S
Eur J Pharmacol; 2011 Jan; 650(1):28-33. PubMed ID: 20887721
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
12. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
Xu H; Lu YF; Rothman RB
Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
[TBL] [Abstract][Full Text] [Related]
13. Differential opioid agonist regulation of the mouse mu opioid receptor.
Blake AD; Bot G; Freeman JC; Reisine T
J Biol Chem; 1997 Jan; 272(2):782-90. PubMed ID: 8995364
[TBL] [Abstract][Full Text] [Related]
14. Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.
Lee KO; Akil H; Woods JH; Traynor JR
Eur J Pharmacol; 1999 Aug; 378(3):323-30. PubMed ID: 10493109
[TBL] [Abstract][Full Text] [Related]
15. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.
Wang D; Raehal KM; Bilsky EJ; Sadée W
J Neurochem; 2001 Jun; 77(6):1590-600. PubMed ID: 11413242
[TBL] [Abstract][Full Text] [Related]
16. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic opioid exposure on guinea pig mu opioid receptor in Chinese hamster ovary cells: comparison with human and rat receptor.
Wallisch M; Nelson CS; Mulvaney JM; Hernandez HS; Smith SA; Olsen GD
Biochem Pharmacol; 2007 Jun; 73(11):1818-28. PubMed ID: 17343833
[TBL] [Abstract][Full Text] [Related]
18. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
[TBL] [Abstract][Full Text] [Related]
19. Agonist-induced signaling and trafficking of the mu-opioid receptor: role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain.
Capeyrou R; Riond J; Corbani M; Lepage JF; Bertin B; Emorine LJ
FEBS Lett; 1997 Sep; 415(2):200-5. PubMed ID: 9350996
[TBL] [Abstract][Full Text] [Related]
20. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
Traynor JR; Nahorski SR
Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
